Skip to Main Content

Paper Details

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
JAMA
156
2021
Author NameAffiliation
Jeremy SugarmanBerman Institute of Bioethics, Johns Hopkins University
David MoherClinical Epidemiology Program, Ottawa Hospital Research Institute, University of Ottawa
Dawn P RichardsClinical Trials Ontario
Joseph S RossYale School of Medicine
Joseph S Ross
An-Wen ChanWomen's College Research Institute, University of Toronto
  • 1 - 6

Datasets